Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic
  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

OurCrowd launches $100M Pandemic Innovation Fund

OurCrowd, the Israeli crowdfunding venture investment platform, today announced the launch of its Pandemic Innovation Fund, with plans to raise a total of $100 million. The money will be invested in “urgent technological solutions for the medical, business, educational and social needs triggered by global pandemics and other health emergencies.” The fund will invest in […]

OurCrowd, the Israeli crowdfunding venture investment platform, today announced the launch of its Pandemic Innovation Fund, with plans to raise a total of $100 million. The money will be invested in “urgent technological solutions for the medical, business, educational and social needs triggered by global pandemics and other health emergencies.”

The fund will invest in startups that look at developing vaccines and tests, as well as therapeutics, remote monitoring, digital health and personal protection. In addition, it’ll also look at startups that focus on continuity and disruption management that focus on remote working, distance learning, robotic process automation, home exercise and cybersecurity. That gives the fund a pretty broad mandate, but it’ll also allow the partners to spread the investments across a variety of industries.

“The rapid spread of the coronavirus has validated our vision of a connected digital world poised to solve any crisis through global communication and rapid response,” said OurCrowd CEO Jon Medved. “To ensure that we get the world back on track, there is now an urgent need for innovation. Technology can help us overcome many of the problems resulting from the crisis. It’s time for tech to move fast and fix things.”

OurCrowd has already invested in a number of companies that would have been a good fit for the new fund if they came along today, including MigVax, which recently raised $12 million for its coronavirus vaccine efforts, as well as Sight Diagnostics, SaNOtize, TytoCare and others.

The principals for the new fund are healthcare exec Dr. Morris Laster, OurCrowd venture partner and chairman of its medical advisory board Dr. Morry Blumenfeld and OurCrowd venture partner David Sokolic.

“Together we must tackle the current pandemic as well as plan for future ones, because this story is just beginning. Entrepreneurs are uniquely skilled to provide fast and effective solutions to some of our greatest challenges. Our new fund will create the bridge between the innovations we need and the far-sighted investors able to provide the resources required to improve our world,” said Laster.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.